i n f l a r x

Loading

Press Release

Home Investors Press Releases Press Release

InflaRx Announces Positive Data from Second Interim Analysis of Ongoing Phase IIa Open Label Study with Vilobelimab in Pyoderma Gangraenosum

Aug 10, 2021

Time to read 4 Minutes

Download PDF

Back